Related Experiment Video
Updated: May 15, 2026
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
Current preclinical models for the advancement of translational bladder cancer research
David J DeGraff1, Victoria L Robinson, Jay B Shah
11Vanderbilt University Medical Center, Nashville,Tennessee, USA.
Abstract:
Bladder cancer is a common disease representing the fifth most diagnosed solid tumor in the United States. Despite this, advances in our understanding of the molecular etiology and treatment of bladder cancer have been relatively lacking. This is especially apparent when recent advances in other cancers, such as breast and prostate, are taken into consideration. The field of bladder cancer research is ready and poised for a series of paradigm-shifting discoveries that will greatly impact the way this disease is clinically managed. Future preclinical discoveries with translational potential will require investigators to take full advantage of recent advances in molecular and animal modeling methodologies. We present an overview of current preclinical models and their potential roles in advancing our understanding of this deadly disease and for advancing care.
Insights
Bladder cancer research needs better molecular understanding and treatment strategies. This review highlights preclinical models crucial for advancing bladder cancer care and discovery.
Area of Science:
- Oncology
- Cancer Research
- Urology
Background:
- Bladder cancer is a prevalent malignancy, ranking as the fifth most diagnosed solid tumor in the U.S.
- Despite its commonality, significant gaps persist in understanding the molecular basis and effective treatments for bladder cancer.
- Progress in bladder cancer lags behind other cancers like breast and prostate, indicating a need for accelerated research.
Purpose of the Study:
- To provide an overview of current preclinical models used in bladder cancer research.
- To discuss the potential of these models in advancing the understanding of bladder cancer's molecular etiology.
- To explore how preclinical models can facilitate the development of novel therapeutic strategies and improve clinical management.
Main Methods:
- Review of existing literature on preclinical models for bladder cancer.
- Analysis of recent advancements in molecular and animal modeling methodologies.
- Discussion of the translational potential of various preclinical models.
Main Results:
- Current preclinical models offer valuable platforms for investigating bladder cancer biology.
- Advances in molecular and animal modeling enhance the predictive power of preclinical studies.
- These models are essential for bridging the gap between basic research and clinical application.
Conclusions:
- The field of bladder cancer research is primed for significant breakthroughs.
- Enhanced utilization of advanced preclinical models is critical for future discoveries.
- Translational research using robust preclinical models will drive improvements in bladder cancer diagnosis and treatment.
